ישראל - עברית - Ministry of Health

taro pharmaceutical industries ltd - selenium sulfide - תרחיף - selenium sulfide 25 mg/ml - selenium sulfide - selenium sulfide - for the treatment of dandruff, seborrheic dermatitis of the scalp and tinea versicolor.

ישראל - עברית - Ministry of Health

novartis israel ltd - lutetium (177lu) oxodotreotide - תמיסה לאינפוזיה - lutetium (177lu) oxodotreotide 370 mbq/ml - lutetium (177lu) oxodotreotide

ישראל - עברית - Ministry of Health

marshall isotope ltd, israel - lutetium (177lu) oxodotreotide - תמיסה לאינפוזיה - lutetium (177lu) oxodotreotide 370 mbq/ml - lutetium (177lu) oxodotreotide

ישראל - עברית - Ministry of Health

marshall isotope ltd, israel - lutetium (177lu) oxodotreotide - תמיסה לאינפוזיה - lutetium (177lu) oxodotreotide 370 mbq/ml - lutetium (177lu) oxodotreotide

ישראל - עברית - Ministry of Health

s.r.y. (medical services ) ltd, israel - lutetium (177lu) oxodotreotide - תמיסה לאינפוזיה - lutetium (177lu) oxodotreotide 600 mbq/ml - lutetium (177lu) oxodotreotide

ישראל - עברית - Ministry of Health

novartis israel ltd - lutetium (177lu) vipivotide tetraxetan - תמיסה להזרקה\אינפוזיה - lutetium (177lu) vipivotide tetraxetan 1000 mbq/ml - lutetium (177lu) vipivotide tetraxetan

ישראל - עברית - Ministry of Health

cts ltd - levetiracetam - טבליות מצופות פילם - levetiracetam 250 mg - levetiracetam - levetiracetam - - keppra is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - keppra is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy. - keppra is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalization in patient from 16 years of age with newly diagnosed epilepsy. - keppra is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

ישראל - עברית - Ministry of Health

cts ltd - levetiracetam - טבליות מצופות פילם - levetiracetam 500 mg - levetiracetam - levetiracetam - - keppra is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - keppra is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy. - keppra is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalization in patient from 16 years of age with newly diagnosed epilepsy. - keppra is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

ישראל - עברית - Ministry of Health

cts ltd - levetiracetam - טבליות מצופות פילם - levetiracetam 1000 mg - levetiracetam - levetiracetam - - keppra is indicated as adjunctive therapy in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - keppra is indicated as adjunctive therapy in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy. - keppra is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalization in patient from 16 years of age with newly diagnosed epilepsy. - keppra is indicated in the treatment of primary gneralized tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.

ישראל - עברית - Ministry of Health

cts ltd - levetiracetam - תמיסה - levetiracetam 100 mg/ml - levetiracetam - levetiracetam - keppra is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy. keppra is indicated as adjunctive therapy - in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy. - in the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic epilepsy. - in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.